tiprankstipranks

Novartis initiated with an Outperform at BNP Paribas Exane

BNP Paribas Exane analyst Peter Verdult initiated coverage of Novartis (NVS) with an Outperform rating and $116 price target

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue